Literature DB >> 29317935

Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

Sarah A Lamb1, Yazid N Al Hamarneh1, Sherilyn K D Houle1, Alexander A Leung1, Ross T Tsuyuki1.   

Abstract

Entities:  

Year:  2017        PMID： 29317935      PMCID： PMC5755821          DOI： 10.1177/1715163517743525

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  56 in total

1.  The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.

Authors:  Ross T Tsuyuki; Yazid N Al Hamarneh; Charlotte A Jones; Brenda R Hemmelgarn
Journal:  J Am Coll Cardiol       Date:  2016-04-04       Impact factor: 24.094

2.  Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy.

Authors:  M Saba; J Diep; B Saini; T Dhippayom
Journal:  J Clin Pharm Ther       Date:  2014-01-13       Impact factor: 2.512

3.  Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice.

Authors:  Giovanni Corrao; Federica Nicotra; Andrea Parodi; Antonella Zambon; Franca Heiman; Luca Merlino; Ida Fortino; Giancarlo Cesana; Giuseppe Mancia
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

Review 4.  The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Kaberi Dasgupta; Robert R Quinn; Kelly B Zarnke; Doreen M Rabi; Pietro Ravani; Stella S Daskalopoulou; Simon W Rabkin; Luc Trudeau; Ross D Feldman; Lyne Cloutier; Ally Prebtani; Robert J Herman; Simon L Bacon; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Mark Gelfer; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Kevin D Burns; Robert J Petrella; Swapnil Hiremath; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Milan Khara; Andrew Pipe; Paul Oh; Peter Selby; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Raj S Padwal; Luc Poirier
Journal:  Can J Cardiol       Date:  2014-02-22       Impact factor: 5.223

Review 5.  Automated office blood pressure measurement in primary care.

Authors:  Martin G Myers; Janusz Kaczorowski; Martin Dawes; Marshall Godwin
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 6.  Telephone counselling for smoking cessation.

Authors:  Lindsay F Stead; Jamie Hartmann-Boyce; Rafael Perera; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2013-08-12

Review 7.  Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Valérie Santschi; Arnaud Chiolero; Gilles Paradis; April L Colosimo; Bernard Burnand
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

8.  No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.

Authors:  Jane Warwick; Emanuela Falaschetti; Kenneth Rockwood; Arnold Mitnitski; Lutgarde Thijs; Nigel Beckett; Christopher Bulpitt; Ruth Peters
Journal:  BMC Med       Date:  2015-04-09       Impact factor: 8.775

9.  A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.

Authors:  J S Benner; L Erhardt; M Flammer; R A Moller; N Rajicic; K Changela; C Yunis; S B Cherry; Z Gaciong; E S Johnson; M C J M Sturkenboom; J García-Puig; X Girerd
Journal:  Int J Clin Pract       Date:  2008-08-07       Impact factor: 2.503

10.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321
View more
  5 in total

1.  Reply from authors.

Authors:  Sarah A Lamb; Yazid N Al Hamarneh; Sherilyn K D Houle; Alexander A Leung; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2018-05-04

2.  Shared decision making and high blood pressure.

Authors:  James McCormack
Journal:  Can Pharm J (Ott)       Date:  2018-04-02

3.  Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China.

Authors:  Ying Li; Guoqin Liu; Chaojie Liu; Xianhong Wang; Yalin Chu; Xiaoqin Li; Wenhao Yang; Yewei Shen; Fang Wu; Wenzhi Zhang
Journal:  Glob Health Sci Pract       Date:  2021-12-21

Review 4.  Hypertension in older adults: Assessment, management, and challenges.

Authors:  Estefania Oliveros; Hena Patel; Stella Kyung; Setri Fugar; Alan Goldberg; Nidhi Madan; Kim A Williams
Journal:  Clin Cardiol       Date:  2019-12-11       Impact factor: 2.882

5.  Quality evaluation of community pharmacy blood pressure (BP) screening services: an English cross-sectional survey with geospatial analysis.

Authors:  Ravina Barrett; James Hodgkinson
Journal:  BMJ Open       Date:  2019-12-11       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.